Position in NVS
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$17,406,420
+$195,009 QoQ
Shares Held
111,067
-1.4% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
2.35%
of 13F equity value
Holder Rank
#126
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WILKINS INVESTMENT COUNSEL INC holds $77,139,543 across 7 Drug Manufacturers - General names. NVS ranks #2 (22.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
244,471 | $31,414,523 | |
| 2 | NVS |
Novartis AG
This page
|
111,067 | $17,406,420 | |
| 3 | JNJ |
Johnson & Johnson
|
66,797 | $16,964,434 | |
| 4 | PFE |
Pfizer Inc
|
176,761 | $4,256,404 | |
| 5 | ABBV |
AbbVie Inc.
|
14,832 | $3,732,324 | |
| 6 | LLY |
ELI LILLY & Co
|
2,484 | $2,979,384 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
6,700 | $386,054 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,406,420 | 111,067 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $17,211,411 | 112,677 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $16,049,722 | 116,412 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $17,181,210 | 133,977 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $16,871,214 | 139,420 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $16,645,636 | 149,315 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $16,229,556 | 166,782 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $21,630,201 | 188,056 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $20,117,639 | 188,969 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $18,159,800 | 187,737 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $13,137,206 | 130,110 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $13,338,567 | 130,950 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $13,395,802 | 132,750 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $12,393,320 | 134,710 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $12,243,571 | 134,960 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $10,168,997 | 133,785 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $11,238,009 | 132,947 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $11,747,970 | 133,880 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $11,615,141 | 132,790 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $10,679,650 | 130,590 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $11,696,055 | 128,190 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $10,780,310 | 126,115 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $11,977,029 | 126,835 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $10,997,831 | 126,470 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $10,816,622 | 123,845 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $10,027,569 | 121,620 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||